Literature DB >> 12812520

Binding of endostatin to endothelial heparan sulphate shows a differential requirement for specific sulphates.

Fiona H Blackhall1, Catherine L R Merry, Malcolm Lyon, Gordon C Jayson, Judah Folkman, Kashi Javaherian, John T Gallagher.   

Abstract

Endostatin is a naturally occurring proteolytic fragment of the C-terminal domain of collagen XVIII. It inhibits angiogenesis by a mechanism that appears to involve binding to HS (heparan sulphate). We have examined the molecular interaction between endostatin and HS from micro- and macrovessel endothelial cells. Two discrete panels of oligosaccharides were prepared from metabolically radiolabelled HS, using digestion with either heparinase I or III, and then examined for their endostatin affinity using a sensitive filter-binding assay. Two types of endostatin-binding regions were identified: one comprising sulphated domains of five or more disaccharides in length, enriched in 6-O-sulphate groups, and the other contained long heparinase I-resistant fragments. In the latter case, evidence from the present study suggests that the binding region encompasses a sulphated domain fragment and a transition zone of intermediate sulphation. The contribution to binding of specific O-sulphate groups was determined using selectively desulphated HS species, namely HS from Hs2st-/- mutant cells, and by comparing the compositions of endostatin-binding and non-binding oligosaccharides. The results indicate that 6-O-sulphates play a dominant role in site selectivity and 2-O-sulphates are not strictly essential.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12812520      PMCID: PMC1223655          DOI: 10.1042/BJ20030730

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  28 in total

Review 1.  Regulated diversity of heparan sulfate.

Authors:  U Lindahl; M Kusche-Gullberg; L Kjellén
Journal:  J Biol Chem       Date:  1998-09-25       Impact factor: 5.157

2.  High level expression and secretion of Fc-X fusion proteins in mammalian cells.

Authors:  K M Lo; Y Sudo; J Chen; Y Li; Y Lan; S M Kong; L Chen; Q An; S D Gillies
Journal:  Protein Eng       Date:  1998-06

3.  Endostatin induces endothelial cell apoptosis.

Authors:  M Dhanabal; R Ramchandran; M J Waterman; H Lu; B Knebelmann; M Segal; V P Sukhatme
Journal:  J Biol Chem       Date:  1999-04-23       Impact factor: 5.157

4.  Inhibitory effect of full-length human endostatin on in vitro angiogenesis.

Authors:  L Taddei; P Chiarugi; L Brogelli; P Cirri; L Magnelli; G Raugei; M Ziche; H J Granger; V Chiarugi; G Ramponi
Journal:  Biochem Biophys Res Commun       Date:  1999-09-24       Impact factor: 3.575

5.  Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding.

Authors:  N Yamaguchi; B Anand-Apte; M Lee; T Sasaki; N Fukai; R Shapiro; I Que; C Lowik; R Timpl; B R Olsen
Journal:  EMBO J       Date:  1999-08-16       Impact factor: 11.598

6.  Collagen XVIII is a basement membrane heparan sulfate proteoglycan.

Authors:  W Halfter; S Dong; B Schurer; G J Cole
Journal:  J Biol Chem       Date:  1998-09-25       Impact factor: 5.157

7.  Structural basis and potential role of heparin/heparan sulfate binding to the angiogenesis inhibitor endostatin.

Authors:  T Sasaki; H Larsson; J Kreuger; M Salmivirta; L Claesson-Welsh; U Lindahl; E Hohenester; R Timpl
Journal:  EMBO J       Date:  1999-11-15       Impact factor: 11.598

8.  Elucidation of the structural features of heparan sulfate important for interaction with the Hep-2 domain of fibronectin.

Authors:  M Lyon; G Rushton; J A Askari; M J Humphries; J T Gallagher
Journal:  J Biol Chem       Date:  2000-02-18       Impact factor: 5.157

9.  Highly sensitive sequencing of the sulfated domains of heparan sulfate.

Authors:  C L Merry; M Lyon; J A Deakin; J J Hopwood; J T Gallagher
Journal:  J Biol Chem       Date:  1999-06-25       Impact factor: 5.157

10.  Heparan sulfate oligosaccharides require 6-O-sulfation for promotion of basic fibroblast growth factor mitogenic activity.

Authors:  D A Pye; R R Vives; J E Turnbull; P Hyde; J T Gallagher
Journal:  J Biol Chem       Date:  1998-09-04       Impact factor: 5.157

View more
  9 in total

Review 1.  Glycoscience finally comes of age.

Authors:  Anthony H Merry; Catherine L R Merry
Journal:  EMBO Rep       Date:  2005-10       Impact factor: 8.807

Review 2.  The "in and out" of glucosamine 6-O-sulfation: the 6th sense of heparan sulfate.

Authors:  Rana El Masri; Amal Seffouh; Hugues Lortat-Jacob; Romain R Vivès
Journal:  Glycoconj J       Date:  2016-11-03       Impact factor: 2.916

3.  E-selectin is required for the antiangiogenic activity of endostatin.

Authors:  Ying Yu; Karen S Moulton; Mohamed K Khan; Sabrina Vineberg; Eileen Boye; Vannessa M Davis; Peter E O'Donnell; Joyce Bischoff; David S Milstone
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-17       Impact factor: 11.205

4.  Endostatin is protective against monocrotaline-induced right heart disease through the inhibition of T-type Ca(2+) channel.

Authors:  Keisuke Imoto; Sayaka Kumatani; Muneyoshi Okada; Hideyuki Yamawaki
Journal:  Pflugers Arch       Date:  2016-03-29       Impact factor: 3.657

5.  Semaphorin 3A binds to the perineuronal nets via chondroitin sulfate type E motifs in rodent brains.

Authors:  Gunnar Dick; Chin Lik Tan; Joao Nuno Alves; Erich M E Ehlert; Gregory M Miller; Linda C Hsieh-Wilson; Kazuyuki Sugahara; Arie Oosterhof; Toin H van Kuppevelt; Joost Verhaagen; James W Fawcett; Jessica C F Kwok
Journal:  J Biol Chem       Date:  2013-08-12       Impact factor: 5.157

Review 6.  Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use.

Authors:  Paola Chiodelli; Antonella Bugatti; Chiara Urbinati; Marco Rusnati
Journal:  Molecules       Date:  2015-04-10       Impact factor: 4.411

7.  The exostosin family of glycosyltransferases: mRNA expression profiles and heparan sulphate structure in human breast carcinoma cell lines.

Authors:  Lawrence F Sembajwe; Kirankumar Katta; Mona Grønning; Marion Kusche-Gullberg
Journal:  Biosci Rep       Date:  2018-08-31       Impact factor: 3.840

Review 8.  The Heparanase Regulatory Network in Health and Disease.

Authors:  Alyce J Mayfosh; Tien K Nguyen; Mark D Hulett
Journal:  Int J Mol Sci       Date:  2021-10-14       Impact factor: 5.923

9.  Extension of the in vivo half-life of endostatin and its improved anti-tumor activities upon fusion to a humanized antibody against tumor-associated glycoprotein 72 in a mouse model of human colorectal carcinoma.

Authors:  Sang-Hyun Lee; In Cheul Jeung; Tae Woo Park; Kyungmin Lee; Dong Gwang Lee; Young-Lai Cho; Tae Sup Lee; Hee-Jun Na; Young-Jun Park; Hee Gu Lee; Mun Sik Jeong; Kwang-Hee Bae; Sang Chul Lee; Hyo Jin Lee; Young-Guen Kwon; Hyo Jeong Hong; Jang-Seong Kim; Jeong-Ki Min
Journal:  Oncotarget       Date:  2015-03-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.